[1] CHEN M, JU Y, CHEN M, et al.Epidemiological and genetic characteristics of EV71 in hand, foot, and mouth disease in Guangxi, southern China, from 2010 to 2015[J].PLoS One, 2017, 12(12):e188640.
[2] 隋美丽, 李懿, 刘新奎, 等.手足口病流行病学, 病原学及重症化机制的研究进展[J].中国病原生物学杂志, 2017, 12(1):92-96.
[3] LI Y, ZHOU Y, CHENG Y, et al.Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18:a test-negative case-control study[J].Lancet ChildAdolesc Health, 2019, 3(10):697-704.
[4] JIANG H, ZHANG Z, RAO Q, et al.The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China[J].Emerg Microbes Infec, 2021, 10(1):619-628.
[5] PONS-SALORT M, OBERSTE M S, PALLANSCH M A, et al.The seasonality of nonpolio enteroviruses in the United States:patterns and drivers[J].Proc Natl Acad Sci U S A, 2018, 115(12):3078-3083.
[6] COHEN R, ASHMAN M, TAHA M, et al.Pediatric Infect Dis Group(GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?[J].Infect Dis Now, 2021, 51(5):418-423.
[7] BAKER R E, PARK S W, YANG W, et al.The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections[J].Proc Natl Acad Sci U S A, 2020, 117(48):30547-30553.
[8] 涂文, 靳淼, 黄晓霞, 等.2021年 4月中国大陆需关注的突发公共卫生事件风险评估[J].疾病监测, 2021, 36(4):303-306.
[9] ZHANG W, HUANG Z, HUANG M, et al.Predicting severe enterovirus 71-infected hand, foot, and mouth disease:cytokines and chemokines[J].Mediators Inflamm, 2020, 2020(9):1-11.
[10] WANG J, ZHOU J, XIE G, et al.The epidemiological and clinical characteristics of hand, foot, and mouth disease in Hangzhou, China, 2016 to 2018[J].Clin Pediatr, 2020, 59(7):656-662.
[11] 中华人民共和国国家卫生和计划生育委员会.手足口病诊疗指南(2018年版)[J].传染病信息, 2018, 25(6):8-13.
[12] NAJAFI-GHOBADI S, NAJAFI-GHOBADI K, TAPAK L, et al.Application of data mining techniques and logistic regression to model drug use transition to injection:a case study in drug use treatment centers in Kermanshah Province, Iran[J].Subst Abuse Treat Prev Policy, 2019, 14(1):1-11.
[13] EDSEL I N G, WANHUA S U, MATTHIAS S, et al.Support vector machines and logistic regression to predict temporal artery biopsy outcomes[J].Can J Ophthalmol, 2019, 54(1):116-118.
[14] HUANG S, CAI N, PACHECO P P, et al.Applications of support vector machine(SVM) learning in cancer genomics[J].Cancer Genomics Proteomics, 2018, 15(1):41-51.
[15] HE L, LI H, DUDLEY J A, et al.Machine learning prediction of liver stiffness using clinical and T2-weighted MRI radiomic data[J].AJR Am J Roentgenol, 2019, 213(3):592-601.
[16] PENG L, LUO R, JIANG Z.Risk factors for neurogenic pulmonary edema in patients with severe hand, foot, and mouth disease:a meta-analysis[J].Int J Infect Dis, 2017, 65:37-43.
[17] LI P, HUANG Y, ZHU D, et al.Risk factors for severe hand-foot-mouth disease in China:a systematic review and meta-analysis[J].Front Pediatr, 2021, 9(10):716039.
[18] 党德建, 朱杰辉, 张超, 等.炎症因子在手足口病重症和重症天数判断中的应用[J].现代预防医学, 2017, 44(20):3817-3821.
[19] SUN B J, CHEN H J, CHEN Y, et al.The risk factors of acquiring severe hand, foot, and mouth disease:a meta-analysis[J].Can J Infect Dis Med Microbiol, 2018, 2018:2751457.
[20] WANG X F, LU J, LIU X X, et al.Epidemiological features of hand, foot and mouth disease outbreaks among Chinese preschool children:a meta-analysis[J].Iran J Public Health, 2018, 47(9):1234-1243.
[21] ZHUO F, YU M, CHEN Q, et al.Development and validation of diagnostic models for hand-foot-and-mouth disease in children[J].Dis Markers, 2021, 2021:1923636.
[22] 马牧原.2013至2018年瓦房店市手足口病流行特征分析[J].现代医学, 2020(12):1545-1550.
[23] JIANG L, WANG J, ZHANG C, et al.Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China[J].Vaccine, 2020, 38(7):1804-1809. |